Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Britta Galling, Amat Calsina Ferrer, Margarita Abi Zeid Daou, Dinesh Sangroula, Katsuhiko Hagi & Christoph U Correll. (2015) Safety and tolerability of antidepressant co-treatment in acute major depressive disorder: results from a systematic review and exploratory meta-analysis. Expert Opinion on Drug Safety 14:10, pages 1587-1608.
Read now
Read now
Articles from other publishers (17)
Rosanna Breaux, Raman Baweja, Hana-May Eadeh, Delshad M. Shroff, Annah R. Cash, Courtney S. Swanson, Amy Knehans & James G. Waxmonsky. (2023) Systematic Review and Meta-analysis: Pharmacological and Nonpharmacological Interventions for Persistent Nonepisodic Irritability. Journal of the American Academy of Child & Adolescent Psychiatry 62:3, pages 318-334.
Crossref
Crossref
Pan Jing, Jianjun Su, Chengying Zheng, Xi Mei & Xiaobin Zhang. (2023) A retrospective study of psychotropic drug treatments in bipolar disorder at acute and maintenance episodes. Frontiers in Psychiatry 14.
Crossref
Crossref
Taku Maruki, Tomohiro Utsumi, Masahiro Takeshima, Yu Fujiwara, Marie Matsui, Yumi Aoki, Hiroyuki Toda, Norio Watanabe, Koichiro Watanabe & Yoshikazu Takaesu. (2022) Efficacy and safety of adjunctive therapy to lamotrigine, lithium, or valproate monotherapy in bipolar depression: a systematic review and meta-analysis of randomized controlled trials. International Journal of Bipolar Disorders 10:1.
Crossref
Crossref
Dagmar Breznoscakova & Maria Pallayova. (2022) Bipolar disorder and type 2 diabetes mellitus: A bidirectional relationship. The European Journal of Psychiatry 36:3, pages 152-162.
Crossref
Crossref
Georgios Schoretsanitis & Michael Paulzen. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1469
1491
.
Nigist Alemayehu Woldekidan, Ammas Siraj Mohammed, Amsalu Degu & Yohannes Tadiwos. (2021) Prevalence of metabolic syndrome and associated factors among psychiatric patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. PLOS ONE 16:8, pages e0256195.
Crossref
Crossref
Ivan Arnold, Julia Dehning, Anna Grunze & Armand Hausmann. (2021) Old Age Bipolar Disorder—Epidemiology, Aetiology and Treatment. Medicina 57:6, pages 587.
Crossref
Crossref
René Ernst Nielsen, Jytte Banner & Svend Eggert Jensen. (2020) Cardiovascular disease in patients with severe mental illness. Nature Reviews Cardiology 18:2, pages 136-145.
Crossref
Crossref
Konstantinos N Fountoulakis, Lakshmi N Yatham, Heinz Grunze, Eduard Vieta, Allan H Young, Pierre Blier, Mauricio Tohen, Siegfried Kasper & Hans Jurgen Moeller. (2020) The CINP Guidelines on the Definition and Evidence-Based Interventions for Treatment-Resistant Bipolar Disorder. International Journal of Neuropsychopharmacology 23:4, pages 230-256.
Crossref
Crossref
Georgios Schoretsanitis & Michael Paulzen. 2019. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
24
.
Young Sup Woo, Won-Myong Bahk, Jung Goo Lee, Jong-Hyun Jeong, Moon-Doo Kim, InKi Sohn, Se-Hoon Shim, Duk-In Jon, Jeong Seok Seo, Kyung Joon Min, Won Kim, Hoo-Rim Song & Bo-Hyun Yoon. (2018) Korean Medication Algorithm Project for Bipolar Disorder 2018 (KMAP-BP 2018): Fourth Revision. Clinical Psychopharmacology and Neuroscience 16:4, pages 434-448.
Crossref
Crossref
Gioia Baggiani, Luca Ambrosiani, Pierfranco Trincas, Caterina Burrai & Alberto Bocchetta. (2018) Psychotropic Medication of Acute Episodes of Mood Disorders: Current Prescription Attitude in Two Psychiatric Wards in Cagliari, Italy. Clinical Practice & Epidemiology in Mental Health 14:1, pages 236-249.
Crossref
Crossref
Trude Seselie Jahr Iversen, Nils Eiel Steen, Ingrid Dieset, Sigrun Hope, Ragni Mørch, Erlend Strand Gardsjord, Kjetil Nordbø Jørgensen, Ingrid Melle, Ole A. Andreassen, Espen Molden & Erik G. Jönsson. (2018) Side effect burden of antipsychotic drugs in real life – Impact of gender and polypharmacy. Progress in Neuro-Psychopharmacology and Biological Psychiatry 82, pages 263-271.
Crossref
Crossref
Jose de Leon & Edoardo Spina. (2018) Possible Pharmacodynamic and Pharmacokinetic Drug-Drug Interactions That Are Likely to Be Clinically Relevant and/or Frequent in Bipolar Disorder. Current Psychiatry Reports 20:3.
Crossref
Crossref
Ya-Mei Bai, Cheng-Ta Li, Shih-Jen Tsai, Pei-Chi Tu, Mu-Hong Chen & Tung-Ping Su. (2016) Metabolic syndrome and adverse clinical outcomes in patients with bipolar disorder. BMC Psychiatry 16:1.
Crossref
Crossref
Konstantinos N. Fountoulakis, Lakshmi Yatham, Heinz Grunze, Eduard Vieta, Allan Young, Pierre Blier, Siegfried Kasper & Hans Jurgen Moeller. (2016) The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm. International Journal of Neuropsychopharmacology, pages pyw100.
Crossref
Crossref
Jian-Ping Zhang, Todd Lencz, Ryan X. Zhang, Masahiro Nitta, Lawrence Maayan, Majnu John, Delbert G. Robinson, W. Wolfgang Fleischhacker, Rene S. Kahn, Roel A. Ophoff, John M. Kane, Anil K. Malhotra & Christoph U. Correll. (2016) Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis. Schizophrenia Bulletin 42:6, pages 1418-1437.
Crossref
Crossref